2025-07-15 - Analysis Report
Okay, here's an analysis of Johnson & Johnson (JNJ) based on the data you provided. I'll present the data with brief analyses in each section, followed by an overall summary.

## Johnson & Johnson (JNJ) Stock Analysis

**Ticker:** JNJ
**Company:** Johnson & Johnson - A multinational corporation that develops and manufactures pharmaceuticals, medical devices, and consumer packaged goods.

### 1. Performance vs. S&P 500 (VOO)

*   **JNJ Cumulative Return:** 15.53%
*   **VOO Cumulative Return:** 95.85%
*   **Absolute Divergence:** -80.31%
*   **Relative Divergence:** 2.9% (This means JNJ's performance is near the lower end of its historical range relative to the S&P 500)

**Analysis:** JNJ has significantly underperformed the S&P 500 (VOO) over the observed period. The relative divergence suggests this underperformance is near the extreme end of historical trends.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
|------------|--------|--------|---------|--------|--------|
| 2015-2017  | 28.0%  | 56.1%  | -1.0%   | -0.0   | 336.2  |
| 2016-2018  | 8.0%   | 56.6%  | -10.0%  | 0.0    | 310.5  |
| 2017-2019  | 18.0%  | 56.6%  | -12.0%  | 0.7    | 351.0  |
| 2018-2020  | 12.0%  | 59.2%  | -8.0%   | 0.3    | 378.7  |
| 2019-2021  | 32.0%  | 59.6%  | -16.0%  | 0.2    | 411.6  |
| 2020-2022  | 7.0%   | 61.4%  | 5.0%    | 0.2    | 425.0  |
| 2021-2023  | -15.0% | 61.4%  | -33.0%  | 0.4    | 377.1  |
| 2022-2024  | -35.0% | 61.4%  | -61.0%  | 0.3    | 348.0  |
| 2023-2025  | -12.0% | 70.1%  | -59.0%  | 0.2    | 377.3  |

**Analysis:**

*   **CAGR:** The Compound Annual Growth Rate has fluctuated, showing periods of strong growth followed by recent negative trends.
*   **MDD:** The Maximum Drawdown indicates significant potential losses, consistently high across different periods.
*   **Alpha:** Negative Alpha values suggest underperformance compared to the market, especially in recent years.
*   **Beta:** Low Beta values indicate lower volatility compared to the market.
*   **Cap:** Market Cap varies over the years, reflecting changing investor sentiment.

### 2. Recent Stock Price Movement

*   **Current Price:** 156.82
*   **Previous Close:** 156.9
*   **Change:** -0.05
*   **5-Day Moving Average:** 156.64
*   **20-Day Moving Average:** 154.21
*   **60-Day Moving Average:** 154.24

**Analysis:** The current price is slightly below the previous close. The 5-day moving average is above the 20 and 60-day moving averages, suggesting a short-term upward trend.

### 3. Market Risk Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.3372 (Low Risk)
*   **RSI:** 77.56 (Overbought)
*   **PPO:** 0.2692
*   **Hybrid Signal:** Cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **Delta_Previous_Relative_Divergence:** -0.2 (Short-term decrease)
*   **Expected Return:** -1008.5%

**Analysis:**

*   The MRI indicates low market risk.
*   The RSI is in overbought territory, which *could* indicate a potential pullback.
*   The negative change from previous close is minimal (-0.05), so no significant volatility event.
*   The negative Delta suggests a recent decline in relative performance.
*   The extremely negative expected return is highly concerning and warrants further investigation. (Most likely, this is a calculation error or based on a flawed model)

### 4. Recent News & Significant Events

*   **2025-07-15:** Major business developments, regulatory changes, or market events.
*   **2025-07-12:** Analyst discussions on recent performance and outlook.
*   **2025-07-11:** Stock volatility influenced by recent news, earnings, or executive actions.
*   **2025-07-13:** Market experts highlight risks and opportunities, advising investors to monitor news.

**Analysis:** The news suggests potential volatility and significant changes affecting JNJ. Monitoring these news sources is crucial.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출        |
|------------|------|-------------|
| 2025-04-23 | 4.57 | 21.89 B$   |
| 2024-10-23 | 1.12 | 22.47 B$   |
| 2024-07-25 | 1.95 | 22.45 B$   |
| 2024-05-01 | 1.35 | 21.38 B$   |
| 2025-04-23 | 1.35 | 21.38 B$   |

**Analysis:**

*   There is duplicate data on the table with 2025-04-23, so need to verify it.
*   EPS has fluctuated over the recent quarters, with the most recent value (4.57) being significantly higher than previous periods.
*   Revenue has remained relatively stable, in the range of $21.38B to $22.47B.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $21.89B   | 66.40%        |
| 2024-12-31   | $22.52B   | 68.35%        |
| 2024-09-30   | $22.47B   | 69.01%        |
| 2024-06-30   | $22.45B   | 69.40%        |
| 2024-03-31   | $21.38B   | 69.55%        |

**Analysis:**

*   Revenue has been relatively consistent over the past five quarters.
*   Profit margin has slightly decreased recently.

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
|--------------|-----------|----------|
| 2025-03-31   | $78.11B   | 14.08%   |
| 2024-12-31   | $71.49B   | 4.80%    |
| 2024-09-30   | $70.16B   | 3.84%    |
| 2024-06-30   | $71.54B   | 6.55%    |
| 2024-03-31   | $70.02B   | 4.65%    |

**Analysis:**

*   Equity has increased significantly in the most recent quarter.
*   ROE has also increased substantially in the most recent quarter, indicating improved profitability relative to equity.

### 7. Overall Summary

Based on the provided data:

*   **Underperformance:** JNJ has significantly underperformed the S&P 500 over the period. The relative divergence suggests this is historically significant.
*   **Mixed Signals:** Recent stock price movement shows a potential short-term upward trend. The RSI indicates the stock might be overbought, suggesting a possible pullback.
*   **Market Risk:** MRI indicates low market risk.
*   **Recent News:** The recent news events point to potential volatility and significant changes affecting JNJ.
*   **Earnings & Financials:** Revenue has been stable, but profit margins have slightly decreased. ROE has significantly improved in the most recent quarter.

**Conclusion:**

JNJ presents a mixed picture. While it is a stable, established company, it has underperformed the broader market. The recent news and financial data suggest potential changes or volatility. The extremely negative expected return is an outlier that should be confirmed.

**Recommendations:**

*   **Further Investigation:** Investigate the reasons for the significant underperformance relative to the S&P 500.
*   **Monitor News:** Closely monitor the news and company announcements to understand the recent developments affecting JNJ.
*   **Verify Expected Return:** Investigate and verify the validity of the extremely negative expected return.  It's highly likely to be erroneous.
*   **Consider Overbought Condition:** Be aware of the potential for a pullback due to the overbought RSI.

**Disclaimer:** This analysis is based solely on the data provided and does not constitute financial advice. You should consult with a qualified financial advisor before making any investment decisions.
